1) Demographic data of patients (age, gender, WHR, BMI). Regarding age there are some data that patients with MetS having myocardial infarction are older [21] , while regarding gender women may have significantly higher rate of MetS during acute coronary syndrome (ACS) than men, and might be significantly older than men having ACS [19] . 2) Laboratory parameters: peak serum levels of cardiac enzymes [CK, (CK-MB fraction expressed in IU/mL)], that were checked every 8 h until peak and descent was documented. Peak serum cardiac enzymes we used as a surrogate for myocardial infarction size. Furthermore we analyzed serum troponin and brain natriuretic peptide (pro-BNP) level at admittance, glycosylated hemoglobin (HbA1c), creatinine, overall cholesterol, low-density lipoprotein (LDL) and HDL fractions, serum triglycerides, presence of microalbuminuria, blood glucose level at admittance, leukocyte count at admittance, fasting glucose at days 4 and 5. 3) Concomitant diseases and previous medical history (glucose intolerance, diabetes mellitus, arterial hypertension, grade of cardiac failure according to Killip classification).
4) Previous medical history (anamnesis of previous myocardial infarction)

Definition of MetS and its components
MetS was defined according to WHO criteria [5] . 1. Diabetes mellitus or glucose intolerance or insulin resistance with two or more following criteria: 2. Hypertriglyceridemia/or low levels of HDL cholesterol 3. Arterial hypertension 4. Android type of obesity/or high BMI index 5. Microalbuminuria Diabetes mellitus was diagnosed by WHO criteria and glucose intolerance was verified by oral glucose tolerance test (OGTT).
Triglycerides, total, HDL and LDL cholesterol were determined from fasting blood sample. By WHO criteria fasting triglycerides level of 1.7 mmol/L or higher states hypertriglyceridemia, low HDL levels are below 0.9 mmol/L in males and 1.0 mmol/L in females.
Blood pressure of more than 130/85 mmHg was measured 3 times in intervals of 10 minutes 3 days in the row if hypertension is registered for the first time, another criterion was positive history of hypertension.
Android type of obesity was determined by WHR stroke in middle-aged males [11] . According to literature MetS is a risk factor for cardiovascular diseases [12] [13] [14] . Some authors say it is particularly prominent in the population of middleaged males [15] , while others find that correlation to be stronger in the older population [16] [17] [18] . Differences in age and in the influence of MetS on cardiovascular morbidity and mortality could be caused by so far undiscovered geographic factors in particular areas of world (Finland versus Australia and New Zealand, respectively).
There are some data about the incidence of MetS in patients with acute myocardial infarction [19] , as well as that MetS predisposes to higher rate of complications like cardiac failure, myocardial reinfarction [20, 21] , and according to some authors also to sudden cardiac death [20, 21] . Some authors state that the presence of MetS even in nondiabetic patients with myocardial infarction predisposes to larger myocardial size and a higher rate of acute renal failure [22] .
Objective
The aim of this study is to determine the infarct size and heart failure incidence in patients suffering from acute coronary syndrome (ACS), relative to the presence of MetS. We analyzed infarct size and heart failure incidence in both groups regarding gender. We also analyzed the influence of particular components of metabolic syndrome on infarct size and heart failure and compared their influence with influence of MetS.
subjects and Methods
Studied group
Our study involved 230 consecutively patients suffering from ACS. All patients were hospitalized in coronary care unit at University Hospital Dubrava, Zagreb, Croatia from January 2006 until January 2007. Patients with subacute myocardial infarction at admittance were not included into the study. The ethics committee of University Hospital Dubrava approved the study.
To all patients the methods and goals of the study were explained, and all patients entering the study gave their written consent. Data were obtained at the time of admittance, and follow-up was obtained during hospitalization.
Data analysis
Data examined and analyzed in this trial were:
cardiac medications either group. Baseline metabolic conditions of study population are shown in (Table 2) , which was particularly emphasized in females having MetS (Fig. 1) . Mean age of patients without MetS was 63.9 years (SD 11.83), while mean age of patients with MetS was 65.7 years (SD 9.68). Statistical probability that these two age averages are equal was 0.239, so it does not enable us to claim them statistically different. In other words age was not found to have confounding effects for differences in myocardial infarction size between two groups (Table 3a and 3b) .
While in patients without MetS myocardial infarction size were significantly larger in males than in females, in MetS group myocardial infarction size was significantly larger in female group, and MetS-female patients were a group with largest myocardial infarction size of all (Fig. 1, Table 3a and 3b).
Mean age of male patients with myocardial infarction without MetS was 62.19, and of females were 66.17, while mean age of males with MetS having myocardial infarction was 64.11, of females 69.3. When using statistical method of analysis of variance (ANOVA) and analyzing myocardial infarction size (expressed as peak MB-CK values) in terms of age and gender, we concluded, that age had no influence on the myocardial infarction size difference between genders (p =0.875) in our group of patients. There is a statistically significant difference according to MetS (p=0.04), but not regarding gender (p=0.810), and there is interactive influence between MetS and gender (p=0.020) (Table 3a and 3b).
All patients with MetS having myocardial infarction had diabetes mellitus/glucose intolerance, so the presence of diabetes mellitus/glucose intolerance again had no confounding effect regarding the difference in myocardial infarction size between males and females.
higher than 0.9 in males, or 0.85 in females or BMI higher than 30 kg/m 2 . Microalbuminuria was measured by semi quantitative method by CLINITEK bands: significant microalbuminuria appeared when level of albumin in urine was 20 mg/L or more, or when albumin/creatinine ratio was 30 mg/g or more.
Definition of heart failure
Congestive heart failure was defined by chest radiography, echocardiography, and/or physical findings as: ventricular (S3), atrial (S4) gallop, tachyarrhythmia, pulsus-alternans-rapid rate, dyspnea, fatigue, ascites, peripheral edema, and liver enlargement, symptoms of pulmonary edema and by increased serum pro-BNP level at admittance. Stage of congestive heart failure in patients based on clinical findings was graded in one of four stages according to Killip classification. Patients having stage II or higher by Killip classification were considered as positive in terms of having heart failure. Increased serum pro-BNP level at admittance was used as additional tool to diagnose/exclude heart failure.
Statistical analysis
Continuous variables were expressed as mean (M) and standard deviation (SD). Dichotomous variables were expressed as percentage. Student's t test was used to compare continuous variables, and Fisher's Exact Test was used to compare dichotomous variables. Additionally, for testing hypotheses that the group or cell means of the dependent variable (MB-CK) are equal, analysis of variance was performed with two factors (MetS components by gender) and age as covariate. A p value < 0.05 was considered to indicate statistical significance. All statistical analyses were performed with the IBM SPSS Statistics 19 software.
results
Among 230 patients with ACS 141 (61.3%) met criteria for MetS according to WHO (similar to data from literature [19] ), while 89 (38.7%) did not have MetS. MetS was present in 92 of 152 male patients (60.5%) and in 49 of 78 females (62.8%), so there were no significant differences in gender. Forty-seven of 230 patients had UA, 91 NSTEMI, and 92 STEMI. Women having ACS were older (mean age 68.28) than men (mean 63.29), and had significant more often low HDL levels (p=0,007). There was no difference in standard When analyzed all other particular components of MetS (arterial hypertension, HDL, triglycerides, microalbuminuria, WHR, BMI), the group of patients with low HDL had also significantly larger myocardial infarction size than group with normal HDL when size of myocardial infarction was expressed by peak MB-CK. While using peak-CK as a "surrogate" for myocardial infarction size, the group of patients with high triglycerides showed statistically significant larger myocardial infarction than group with normal triglycerides (Table 2) .
Since MB-CK is more sensitive and more specific for cardiac muscle, we can conclude that patients with (Table 4) .
MetS, diabetes mellitus/glucose intolerance and low HDL are at risk of having larger myocardial infarction, because they had statistically significantly larger myocardial infarction than their "counterpart" groups. When using ANOVA to analyze particular components of MetS and their influence on differences in MI size according to gender, most of this influence could be attributed to diabetes mellitus/glucose intolerance. † ANOVA with factors a by b, with age as covariate; p a sig. of factor a, p b sig. of factor b, p a×b sig. of interaction, p age sig. of covariate. *, statistically significant possible influence on heart failure, we can see that in subgroups of patients with microalbuminuria, elevated WHR, and high BMI, there is a tendency toward having higher rate of cardiac failure during ACS, although this is not statistically significant (Table 5) .
If we analyze some other laboratory parameters that might have influenced myocardial infarction size and heart failure such as elevated leukocyte count at admittance, elevated blood sugar at admittance and elevated serum creatinine level we found a correlation between elevated creatinine at admittance and heart failure (Table 6a), while there was no correlation with myocardial infarction size (Table 6b ).
When analyzing all 230 patients with ACS, the presence of cardiac failure was also significantly higher in the MetS group. Eighty-nine out of 230 patients have developed heart failure during ACS (grade Killip II or more). While only 28.1% of patients with heart failure were from non-MetS group (25 patients), even 71.9% of patients with heart failure (64 of them) were from the MetS group (Fig. 2) , which was again relatively more prominent in females (Fig. 3) .
When analyzing according to MetS presence, 71.9% (64) of patients without MetS did not develop heart failure, and only 28.1% (25) had, while in MetS group even 45.4% (64 of 141) developed heart failure [p=0.012, Odds ratio=2.128 (Table 5) ]. We can conclude that MetS increases the chances of having heart failure during ACS.
Regarding cardiac failure aside from MetS group, diabetes mellitus/glucose intolerance group had also statistically significant higher cardiac failure by Killip classification than the group without diabetes mellitus/ glucose intolerance. While in patients without diabetes/glucose intolerance only 27.4% had heart failure and 72.6% did not, even 43.9% of patients with diabetes mellitus/glucose intolerance developed heart failure (p=0.020, Odds ratio=2.078).
When analyzing other components of MetS and their Otherwise, gender differences in the size of infarction and clinical outcome of patients with acute myocardial infarction may be explained in part by the female status. Several conditions found only in women may hint at differences in the pathophysiology of ischemic vascular disease between sexes, including early menopause, gestational diabetes, peripartum vascular dissection, preeclampsia and eclampsia, polycystic ovarian syndrome, low-birth-weight children, and hypothalamic hypoestrogenemia. Females also have a higher prevalence of vascular diseases like Raynaud's phenomenon, migraines, and other vasospastic disorders. There is also evidence that sex hormones play a role in the pathophysiology of vascular disease. Changes in estrogen and androgen balance occur during pregnancy, during the peripartum period, and with the use of oral contraceptives or hormone replacement therapy. Additionally, the aging process heralds a marked reduction in estrogen levels. The predominant source of estrogen before menopause is estradiol. After menopause, a lower level of estrogen is produced primarily from the conversion of androgens to estrone in adipose tissue. These variations have implications for the differences in ischemic heart disease between the sexes and are coincident with the rise in risk for women that occurs after menopause. Further evidence that may help to explain variations in coronary artery disease outcome are gender differences in vascular anatomy. Women typically have smaller and less compliant conduit arteries than men. Age-related stiffening of the aorta appears more prominent in diabetic women than men. Additional evidence for sex-related differences in arterial size and remodeling comes from data on transplant and transgender patients. These data support the concept of differences in vascular physiology based on sex hormone status. There appears to be enlargement with androgens, consistent with positive remodeling. The latter may itself be an independent marker of vascular disease [39] .
Similar to some previous studies, the incidence of MetS was high [19, 40] , around 60%. MetS was associated with a higher rate of cardiac failure following ACS, while so far there are data about higher rates of heart failure following myocardial infarction [21] (in the present study patients with unstable angina were not involved). There is also a tendency toward higher discussion MetS is a well known risk factor for CVD [12] [13] [14] . Regarding particular components of metabolic syndrome there are many trials investigating diabetes mellitus and the worse outcome following myocardial infarction [23] [24] [25] . There is also evidence that high triglycerides and low HDL, as well as elevated triglycerides/HDL ratio predict first coronary syndrome in men [26] , all cause mortality in women with suspected myocardial ischemia [27] , and extensive coronary disease [28] . According to some authors, hypertriglyceridemia is associated with cardiovascular disease (CVD) and MetS [29] .
Regarding hypertension and ACS, there are some data that antecedent hypertension predicts heart failure in patients with myocardial infarction [30] .
Regarding obesity and myocardial infarction some authors state that BMI is inversely related to mortality during myocardial infarction (unlike WHR) [31, 32] , while others state that central obesity is associated with larger myocardial necrosis during myocardial infarction [33] . On long term data the findings are not consistent, and while some authors state that abdominal obesity is an independent predictor of all-cause mortality following myocardial infarction particularly in men [34] , others state BMI has no influence on survival following myocardial infarction [35] .
There are some trials showing that microalbuminuria is a predictor of increased risk for complications following myocardial infarction [36] and that patients with microalbuminuria have larger myocardial infarction size, even nondiabetic, hypertensive patients [37] . Others state that microalbuminuria during myocardial infarction is a strong predictor for 1-year mortality [38] . This is the first study to our knowledge demonstrating that females with acute myocardial infarction and MetS have larger infarct size than males, which is opposite to the group without MetS. Although females with MetS having myocardial infarction were older, and more often had low HDL levels, statistical analysis showed that age and low HLD levels had no confounding effect. In the group of patients with myocardial infarction, but without MetS, females were also older than males, but males had larger myocardial infarction than females, so the cause of larger myocardial infarction in females lies somewhere else.
Much but not all of this gender disparity can be attributed to differences in age and attendant comor-m 2 ), normal WHR or no microalbuminuria (Table 5 ).
Although it is well known that the incidence of MetS during acute myocardial infarction is high and that it predisposes to higher rate of complications [21] , MetS is, however, still under-diagnosed and under-treated [41] . Recognizing MetS in patients during ACS as of very high risk for larger infarction size and heart failure rate (especially in females) leads us to pay more attention to this group of patients, during hospitalization as well on discharge.
learning Points "Metabolic syndrome influencing infarct size and heart failure in patients with acute coronary syndrome -does gender matter?"
• Patients with MetS have larger myocardial infarction than patients with no MetS. • In the group of patients with no MetS, males have larger myocardial infarction size than females. • In the group of patients with MetS, females have larger myocardial infarction size than males.
• Patients with MetS have higher rate of heart failure during ACS than non-MetS patients, which is particularly prominent in females.
• Since females with MetS having ACS are a group at higher risk for having larger myocardial infarction and heart failure, all females with MetS having ACS should probably receive more intensive surveillance during hospitalization, and probably urgent coronarography, regardless of which type of ACS they have.
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percentage of cardiac failure in females with MetS having ACS, not previously described in literature.
To our knowledge, it is also the first study "facing" MetS directly versus its components in terms of comparing risk for larger myocardial infarction size and cardiac failure. In that manner we found that MetS group had statistically significant larger myocardial infarction in the terms of peak CK and MB-CK than nonMetS group, which matches with data from literature [22] . The mechanism predisposing for larger myocardial infarction and cardiac failure in MetS patients might be advanced atherosclerosis and/or endothelial dysfunction in this group of patients. Those patients are more prone to coronary artery disease, which is probably more severe in patients having at the same time diabetes/glucose intolerance, hypertension, dyslipidemia, obesity, and microalbuminuria (components of MetS).
When analyzing particular components of MetS, diabetes mellitus/glucose intolerance group and low HDL group had larger myocardial infarction size than groups with no diabetes/glucose intolerance and normal HDL, respectively. Other components of MetS (hypertension, increased BMI, microalbuminuria, elevated WHR) did not appear to be either predictors of larger myocardial infarction size, or cardiac failure when compared with groups with no hypertension, normal BMI, no microalbuminuria and normal WHR in this study. Regarding high triglyceride levels we can conclude that it might be of importance in terms of myocardial infarction size, but not as high important as MetS, diabetes mellitus/ glucose intolerance or low HDL.
Regarding heart failure during ACS, again groups with MetS and diabetes mellitus/glucose intolerance had higher percentage of heart failure than the control groups. In the groups of patients with elevated BMI, elevated WHR and microalbuminuria there is a tendency toward higher rate of cardiac failure when compared with groups with normal BMI (beyond 30 kg/
